Compare PVH & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PVH | IRTC |
|---|---|---|
| Founded | 1881 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.9B |
| IPO Year | 1994 | 2016 |
| Metric | PVH | IRTC |
|---|---|---|
| Price | $90.20 | $120.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 13 |
| Target Price | $90.53 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 1.0M | 436.2K |
| Earning Date | 06-03-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $8,950,200,000.00 | $747,138,000.00 |
| Revenue This Year | $1.89 | $19.60 |
| Revenue Next Year | $1.86 | $15.94 |
| P/E Ratio | $170.35 | ★ N/A |
| Revenue Growth | 3.44 | ★ 26.24 |
| 52 Week Low | $59.60 | $112.31 |
| 52 Week High | $100.15 | $210.01 |
| Indicator | PVH | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 47.79 |
| Support Level | $72.61 | $119.48 |
| Resistance Level | $100.15 | $127.50 |
| Average True Range (ATR) | 3.34 | 6.72 |
| MACD | -1.32 | -0.04 |
| Stochastic Oscillator | 26.73 | 38.68 |
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, roughly 1,400 standalone stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.